Optical molecular imaging developer raises $3.1M in Series A funding

    Jan. 2, 2015
    Optical molecular imaging technology developer Lightpoint Medical has raised $3.1 million in Series A financing.

    Optical molecular imaging technology developer Lightpoint Medical (Rickmansworth, Hertfordshire, England) has raised $3.1 million (£2 million) in Series A financing. Investors included Oxford Technology and business angel networks Cambridge Capital Group, London Business Angels, Envestors, Ruffena Capital, and crowdfunding platform SyndicateRoom.

    Lightpoint Medical's technology, which is based on Cerenkov luminescence imaging, can help detect cancer in real time during surgery and reduce the need for repeat operations. The company has clinical trials underway in breast, prostate, and stomach cancers.

    The company will use the investment funding to help bring its LightPath specimen analyzer for intraoperative tumor margin assessment and EnLight molecular imaging fiberscope to the U.S. and European markets in 2015.

    Continue Reading

    Sponsored Recommendations

    March 31, 2025
    Enhance your remote sensing capabilities with Chroma's precision-engineered optical filters, designed for applications such as environmental monitoring, geospatial mapping, and...
    March 31, 2025
    Designed for compatibility with a wide range of systems, Chroma's UV filters are engineered to feature high transmission, superior out-of-band blocking, steep edge transitions...
    March 31, 2025
    Discover strategies to balance component performance and system design, reducing development time and costs while maximizing efficiency.
    March 31, 2025
    Filter accessories including cubes, sliders, and rings, designed to enhance the performance and versatility of optical systems. These components ensure precise alignment and stability...

    Voice your opinion!

    To join the conversation, and become an exclusive member of Laser Focus World, create an account today!